Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Can-Am HIFU is a specialized healthcare provider based in Toronto, Canada, that offers High-Intensity Focused Ultrasound (HIFU) for the non-invasive treatment of localized prostate cancer. As the first Sonablate HIFU center in North America, the company has performed over 2,500 procedures, providing an outpatient alternative to traditional surgery and radiation. Their approach focuses on focal therapy, which precisely targets and ablates cancerous tissue while preserving surrounding healthy structures to minimize side effects like incontinence and erectile dysfunction. In addition to clinical treatments, Can-Am HIFU operates a training and certification program for urologists across North America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Can-Am HIFU.